Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Cash & Current Investments (2018 - 2025)

Dna X (SONM) has disclosed Cash & Current Investments for 8 consecutive years, with $2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Current Investments fell 76.41% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Sep 2025, down 76.41%, and an annual FY2024 reading of $8.0 million, up 2588.96% over the prior year.
  • Cash & Current Investments was $2.1 million for Q3 2025 at Dna X, down from $5.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $15.5 million in Q3 2022 and bottomed at $299000.0 in Q4 2023.
  • Average Cash & Current Investments over 5 years is $8.0 million, with a median of $8.5 million recorded in 2023.
  • The sharpest move saw Cash & Current Investments crashed 97.74% in 2023, then skyrocketed 2588.96% in 2024.
  • Year by year, Cash & Current Investments stood at $2.5 million in 2021, then skyrocketed by 419.99% to $13.2 million in 2022, then plummeted by 97.74% to $299000.0 in 2023, then surged by 2588.96% to $8.0 million in 2024, then crashed by 73.42% to $2.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for SONM at $2.1 million in Q3 2025, $5.4 million in Q2 2025, and $4.9 million in Q1 2025.